semaglutide and the heart FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection Long-Term SELECT Trial: Semaglutide Cuts

Description

This medication is highly teratogenic (can cause birth defects) and requires participation in the MHRA Pregnancy Prevention Programme for women of childbearing potential, along with regular monitoring of blood tests

These tests, however, are not without limitations, and in cases of diagnostic uncertainty due to indeterminate scores, further testing may be indicated

[47] And, leads to dampened systemic inflammation that may be relevant in autoimmune and chronic inflammatory diseases.[47][47][48][49] GLP-1 RA act as multi-faceted anti-inflammatory agents , suggesting they may delay or attenuate inflammation-driven tissue damage.[48][49] GLP-1 receptor agonists very often dampen immune responses